Home
LRMR

LRMR

Larimar Therapeutics Inc.

as of 11-28-2025 12:41pm EST

$3.56

+$0.03

+0.71%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Chart Type:

Time Range:

Founded:	N/A	Country:	United States
Employees:	N/A	City:	BALA CYNWYD
Market Cap:	332.1M	IPO Year:	N/A
Target Price:	$16.71	AVG Volume (30 days):	1.6M
Analyst Decision:	Strong Buy	Number of Analysts:	7
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-1.95	EPS Growth:	N/A
52 Week Low/High:	$1.61 - $6.91	Next Earning Date:	11-05-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered LRMR Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold

Model Accuracy: 72.97%

72.97%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full LRMR Forecast & Prediction with Hourly Data

Compare LRMR vs Leading Stocks

See how LRMR stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free LRMR Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "LRMR Larimar Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.